secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2026-06-04T21:19:08+00:00
Accession:  0001299130-26-000092
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 16M share increase in equity plan at Pacific Biosciences annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2020 Equity Incentive Plan, adding 16,000,000 shares for future grants.
- Four Class III directors elected: Ericson, Ordoñez, Smith, Gibson, Henry, Milligan.
- Ernst & Young ratified as independent registered public accounting firm for FY2026.
- Advisory say-on-pay proposal approved with 114,050,930 votes for, 21,239,989 against.
- Annual meeting had ~65% of shares represented (203,009,375 of 310,487,099 outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/pacb-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001299130-26-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer